medigraphic.com
ISSN 2007-6509 (Print)
Órgano oficial de la Asociación Mexicana de Medicina Transfusional A.C.

2011, Number 2

<< Back Next >>

Rev Mex Med Transfus 2011; 4 (2)

Donors’ haemovigilance

Palomino MR

Language: Spanish
References: 16
Page: 111-115
PDF size: 57.33 Kb.


ABSTRACT

Donations of whole blood and apheresis are very safe, but adverse reactions are frecuently presented and have been documented over the years. The frequency, severity, intensity and duration of adverse reactions to donation have been classified in an effort to systematize its identification, reporting, assessment and treatment. In this article blood donations adverse reactions classifications are presented with some reports of its prevalence in the world and the experience reported in two donation centers in Mexico City.


REFERENCES

  1. Bueno JL. Do we really know the real risks of apheresis donation? ISBT Sciencie Series 2007; 2: 68-74.

  2. Jorgensen J. Donor vigilance. ISBT Science Series 2008; 3: 48-53.

  3. Stegmayr BG, Ivanovich JM, Korach RG et al. Word apheresis association-world apheresis registry. Transfus and Apher Scien 2005; 32: 205-207.

  4. Winders JL. Complications of donor apheresis. Transfus Apher Sci 2006; 21: 132-41.

  5. Tomita T, Takayanagi M, Kiwada K, Mieda A et al. Vasovagal reactions in apheresis donors. Transfus 2002; 42: 1561-66.

  6. Newman BH. Adverse effects in blood donors after whole-blood donation: a study of 1,000 blood donors interviewed 3 weeks after whole-donation. Transfus Med Rev 2003; 43: 598-603.

  7. Newman BH. Blood donor suitability and allogeneic whole blood donation. Transfus Med Rev 2001; 15: 234-244.

  8. Newman BH, Waxman DA. Blood donation-related neurologic needle injury: evaluation of 2 year’s worth of data from a large blood bank. Transfus Med Rev 1996; 36: 213-215.

  9. Newman BH. Blood donor complications after whole blood donation. Curr Opin Haematol 2004; 11: 339-345.

  10. Despotis GJ, Goodnough LT, Dynis M et al. Adverse events in platelet apheresis donor: a multivariate analysis in a hospital-based program. Vox Sang 1999: 7724-32.

  11. Grocco I, Franchini M, Garozzo G et al. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. Blood Transfuse 2009; 7: 35-8.

  12. Caffrey EA. Buttler: Establishing a national adverse event reporting system for blood donors a prospective study of 1.8 million attendances in England and North Wales. Vox Sang 2005; 89 (Suppl 1): 114.

  13. Eder AF, Dy BA, Kennedy JM et al. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfus 2008; 16: 1809-20.

  14. Aguirre GG, Cervantes P, Cortés MS. Factores de riesgo para desarrollar reacción vasovagal en donadores postsangría. Revista de Hematologia 2001; 2: 98-103.

  15. Rojas SL, Luna LM. Domínguez AM. Reacciones adversas a la donación de sangre. Revista Mexicana de Enfermería Cardiológica 2007; 15: 45-46.

  16. Eder AF, Dy BA, Kennedy JM et al. The American Red Cross donor vigilance program complications of blood donation reported in 2006. Transfusion 2008; 48: 1809-19.




2020     |     www.medigraphic.com